Could black seed oil help kids with asthma breathe easier?
NCT ID NCT07315555
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adding black seed oil (Nigella sativa) to standard asthma medication can improve asthma control and lung function in children aged 6–18 with moderate persistent asthma. Ninety children will receive either a low or high dose of black seed oil capsules or a placebo, alongside their usual inhaled steroids. The goal is to see if this natural supplement can reduce inflammation and help them breathe better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Nigella sativa (black seed) oil
- What this could lead to
- If it works, this could point toward a natural supplement that helps children with asthma breathe better and have fewer symptoms when added to their usual medication.
- What could go wrong
- This is a small, early-stage trial with only 90 children. The supplement may not provide significant benefit, and results may not apply to all asthma patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMMUNITY-ACQUIRED PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Flu vaccine showdown: which shot protects seniors best?
- Can inhaled nitric oxide speed pneumonia recovery?
- Pneumonia culprit may be rarer than doctors think
- Shorter antibiotic course may be just as effective for kids with pneumonia
- Shocking muscles back to health: could zaps help seniors recover from lung illness?
- New breathing device may reduce need for ventilator in pneumonia patients